QRILL Aqua now approved for import in the Canadian market
Following its FDA approval in June 2022, QRILL™ AQUA continues to make headway in the North American market with its recent...
Puerto Varas, February 2024. Aker BioMarine (AKBM), an innovative company specialized in biotechnology and Antarctic krill...
Aker BioMarine’s QRILL Aqua team will be at stand #3666 at the global VIV Asia trade show in Bangkok from 8-10 March 2023.
The QRILL™ Aqua team was in full swing in 2022, sharing new knowledge about krill, engaging with aquaculture customers and...
Following its FDA approval in June 2022, QRILL™ AQUA continues to make headway in the North American market with its recent...
Aker BioMarine, a conference sponsor, shared insights on how Antarctic krill is a sustainable solution for the evolving...
Aker BioMarine is headed to Singapore to attend World Aquaculture Singapore (WAS) from November 29 to December 2. This event...
For the first time ever, Aker BioMarine will attend AQUA EXPO 2022, (Guayaquil, Ecuador, from October 17-20) to meet with...
Oslo, Norway, September 21, 2022: Aker BioMarine continues to make headway in Indonesia, a key strategic market for the...
Oslo, September 6, 2022: Aker BioMarine is enhancing its QRILL™ Aqua sales organization after successfully recruiting two...